Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.
about
Incidence and Mortality Risks of Cancer in Patients with Type 2 Diabetes: A Retrospective Study in Shanghai, ChinaEnvironmental risk factors for pancreatic cancer: an update.High risk factors of pancreatic carcinoma.Pooling prospective studies to investigate the etiology of second cancers.Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.Diabetic oncopathy--one more yet another deadly diabetic complication!A pooled analysis of body mass index and pancreatic cancer mortality in african americans.Diabetes, pancreatic cancer, and metformin therapy.Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies.Risk factors for pancreatic cancer: a summary review of meta-analytical studies.Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.Expansion of anti-mesothelin specific CD4+ and CD8+ T cell responses in patients with pancreatic carcinoma.Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis.Effect of Body Mass Index on Overall Survival of Pancreatic Cancer: A Meta-AnalysisLeptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production.Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational StudyCentral adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies.New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.Investigating Physical Activity in the Etiology of Pancreatic Cancer: The Age at Which This Is Measured Is Important and Is Independent of Body Mass IndexDynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis.Cutaneous clear cell/signet-ring cell squamous cell carcinoma arising in the right thigh of a patient with type 2 diabetes: combined morphologic, immunohistochemical, and etiologic analysis.Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study.The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas.Nut consumption and risk of pancreatic cancer in women.Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study.Genetic variability in energy balance and pancreatic cancer risk in a population-based case-control study in Minnesota.Type 2 diabetes mellitus is associated with increased risk of pancreatic cancer: A veteran administration registry study.A molecular rheostat at the interface of cancer and diabetesDiabetes mellitus as a novel risk factor for gastrointestinal malignancies.Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis.Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis.The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study.A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma.Time-Dependent Risk of Cancer After a Diabetes Diagnosis in a Cohort of 2.3 Million Adults.Body mass index does not affect the survival of pancreatic cancer patients.Cancer incidence in Canada: trends and projections (1983–2032).The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study.Editorial: Mendelian Randomization Analysis Identifies Body Mass Index and Fasting Insulin as Potential Causal Risk Factors for Pancreatic Cancer Risk.
P2860
Q28597192-9B0B4F83-DA21-4D05-B522-1DD81BE903F5Q30248417-750668CD-E71F-4481-AB4B-DC59FCE214F8Q30249161-2E48F722-2954-43AC-83E3-5397D8A57409Q33992357-83AF01B7-3501-4B80-86CB-64CDD8402E61Q34250010-99DAF127-C918-4C58-B41F-92C68D818E4FQ34272097-5DCDBF23-213E-4CC4-A04F-AE97B1232F19Q34288054-DC51BDFB-BDFF-46D0-A9B3-C79996831DB3Q34471173-F5178FF0-8F5C-4F97-8D81-4425D6DF3F5CQ34586212-6478B889-8238-47B7-B1B0-17D91EBFBFEDQ34660246-AC22242B-9E63-45F8-A4A5-3160977D2C93Q34667061-F9C9581D-E17F-4F33-958C-835E399FBB47Q35063344-B0640A5F-D19F-4570-B97B-8E8E2310E064Q35092711-51BE47FE-01E3-4ADB-AA9C-151B96CBE04DQ35724058-D1755483-F9D8-459C-AFC0-3D259368E488Q35983454-3886C8AF-E519-4661-9057-9A2C8CE20B07Q36140748-AE291128-0C5E-4D0E-888A-99EF2306B1E0Q36182971-B0926306-8A2F-45A5-98AD-76EB11230592Q36207909-0F2FC6DA-7DE6-410B-91A8-8204869469A2Q36443863-B92BE004-C4CE-4E89-81C2-B65983A76714Q36549529-FA82C895-E2FB-4933-BF07-5274116343DCQ36557279-B2CA37C4-6185-4AA1-9F47-901E39152CF7Q36785741-3C938E74-5C4F-400D-891B-6BD49D548EE6Q37255199-29A18CB2-FFC6-4201-A583-476D0AE1B73FQ37277702-C4F535EA-6620-47C7-AA72-937DB58B6F3DQ37352599-7D2E7E05-E3BE-4E18-88DD-C7307A489855Q37490985-6F64D45E-3E4D-44BF-8FE9-9242CE8B2305Q37623325-B400DFDB-7C5F-4500-86C3-B14892448B49Q37705332-48C54439-49F3-411F-A401-1A1BE3AEB447Q38103727-618DC6A2-348E-4E1B-A273-606B6AD037DBQ38270208-253919FA-3742-4ACB-AB5E-191DD61BDD34Q38379281-3B9B8F01-2663-4179-8E65-116829DCF8D8Q38612828-AB411D8E-580C-4C59-9D67-7FB2E167FA4EQ38650099-53F6A99E-ACA6-42D3-A3D8-8FF53A63F7DDQ40255128-68F1D445-5943-4F81-82B9-ECB9554B5336Q40610844-98E6357F-B38F-401F-A573-4F77675B27B1Q40721239-FFB67039-1018-42F9-8EA7-F0B6896116AEQ42183979-E286BB6F-55AC-4F67-A07E-C08B2A05FD29Q46495297-E0D9940D-D37E-4C2D-9B07-6F47E5835524Q47139685-CDB5F9D7-4C40-4212-8201-E0D49026ABCDQ49716938-F180C5A4-990B-4741-B3A0-5EBE1B7BB9F8
P2860
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Diabetes and risk of pancreati ...... atic cancer cohort consortium.
@ast
Diabetes and risk of pancreati ...... atic cancer cohort consortium.
@en
type
label
Diabetes and risk of pancreati ...... atic cancer cohort consortium.
@ast
Diabetes and risk of pancreati ...... atic cancer cohort consortium.
@en
prefLabel
Diabetes and risk of pancreati ...... atic cancer cohort consortium.
@ast
Diabetes and risk of pancreati ...... atic cancer cohort consortium.
@en
P2093
P2860
P50
P1476
Diabetes and risk of pancreati ...... atic cancer cohort consortium.
@en
P2093
Alan A Arslan
Alpa V Patel
Andrea LaCroix
Brian M Wolpin
Dominique S Michaud
Emily Steplowski
Eric J Jacobs
Gloria Petersen
J Michael Gaziano
Joanne W Elena
P2860
P2888
P356
10.1007/S10552-012-0078-8
P50
P577
2012-10-31T00:00:00Z